Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy

Oral Oncology Reports · Published 2025-12-17 · DOI 10.1016/j.oor.2025.100780

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.oor.2025.100780

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

HER3 and HPV in head and neck squamous cell carcinoma: Potential implications of induction chemotherapy on tumor immune microenvironment · Oral Oncology Reports · 2026 · Same journal
Value of alpha smooth muscle actin (αSMA) and inducible nitric oxide synthase (iNOS) in oral squamous cell carcinoma (OSCC): An immunohistochemical approach to tumor stroma categorization and clinicopathological parameters · Oral Oncology Reports · 2025 · Same journal
Hypofractionated adjuvant radiotherapy in cutaneous squamous cell and basal cell carcinoma of the head and neck: 50(Gy) in 20 study · Oral Oncology Reports · 2025 · Same journal
Genetic variants in immune mediators as potential molecular biomarkers for oral cancer evaluation: Insights from a systematic revaluation by computational analyses and Bayesian approaches · Oral Oncology Reports · 2025 · Same journal
Utilization of ChatGPT as a reliable aide for differential diagnosis of histopathology in head and neck surgery · Oral Oncology Reports · 2025 · Same journal
Compromised cervical lymphatic drainage following lymphadenectomy and radiation: an overview of head and neck lymphedema and its emerging pathophysiological implications · Oral Oncology Reports · 2026 · Same journal
Oral care practices and oral mucositis in adult cancer patients receiving chemotherapy, or radiation therapy, or both in a private tertiary care hospital, Karachi, Pakistan · Oral Oncology Reports · 2026 · Same journal
Treatment of recurrent oral carcinoma cuniculatum with immune checkpoint blockade: A case report and literature review · Oral Oncology Reports · 2025 · Same journal
Transforming malignant salivary gland tumor (MSGTs) treatment with AlphaFold: A promising approach · Oral Oncology Reports · 2025 · Same journal
Dysregulation of glucose-6-phosphate dehydrogenase in head and neck squamous cell carcinoma: Pathways, mutations, and therapeutic opportunities · Oral Oncology Reports · 2025 · Same journal